Dimethyl Sulfoxide
CAS 67-68-5
Dimethyl Sulfoxide (CAS 67-68-5) is a Phase 4 pharmaceutical compound with 1 bioactivity target and 149 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 64 ug.mL-1 | 4 | - |
| - | GI50 | 130000 nM | 2 | - |
| - | MIC | 187.5 uL/ml | 2 | - |
| - | IC50 | 20800 nM | 1 | - |
| - | Ki | 10700 nM | 1 | - |
| Cereblon isoform 4 Unclassified |
Ki | 4.97 | - | Magnetospirillum gryphiswaldense |
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Respiratory depression | 19 | 66.188 | 10038678 |
| Trigemino-cardiac reflex | 8 | 57.799 | 10069828 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| DMSO | 3455 | SU | MTHSPL |
| Dimethyl Sulfoxide | 3455 | SU | MTHSPL |
| DIMETHYL SULFOXIDE | 3455 | SU | MTHSPL |
| dimethyl sulfoxide | 3455 | SU | MTHSPL |
| dimethyl sulfoxide | 3455 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Dimethyl Sulfoxide used for in pharmaceutical contexts?
Dimethyl Sulfoxide (CAS 67-68-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Dimethyl Sulfoxide?
Dimethyl Sulfoxide has 149 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Respiratory depression, Trigemino-cardiac reflex, Abdominal discomfort, Abdominal distension, Abdominal pain. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Dimethyl Sulfoxide also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for DMSO (Dimethyl Sulfoxide) with EU status "prohibited".
What clinical phase is Dimethyl Sulfoxide in?
Dimethyl Sulfoxide is rendered with ChEMBL max phase 4 (approved).
What bioactivity targets are documented for Dimethyl Sulfoxide?
Dimethyl Sulfoxide has 6 bioactivity rows in this page query. Rendered target entries include Cereblon isoform 4.